Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Xometry Projects Strong Start and Growth for 2024

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Xometry is projecting a strong start to the year, with expected revenue in Q1 2024 ranging from $118 million to $120 million, marking a 12%-14% increase from the previous year. The company also predicts an Adjusted EBITDA loss of $7.0-$9.0 million for the same period.

Looking further into fiscal 2024, Xometry is optimistic about marketplace revenue, forecasting a growth of at least 20% year-over-year. However, supplier services revenue is expected to decline by approximately 10% due to the discontinuation of certain sales and services.

Xometry’s goal for 2024 is to achieve Adjusted EBITDA profitability by the third quarter, with improved operating leverage helping to offset investments in international and enterprise growth.

XMTR Stock Shows Modest Increase on February 29, 2024

On February 29, 2024, XMTR stock showed positive performance, closing at $30.61, which was a $0.22 increase from the previous market close. This represented a 0.72% rise in the stock price. Despite the positive performance during regular trading hours, XMTR stock remained unchanged in after-hours trading. This suggests that investors may be taking a cautious approach towards the stock. Overall, XMTR stock showed a modest increase on February 29, 2024, reflecting a positive sentiment among investors. Investors should continue to monitor market trends and company developments to make informed decisions regarding XMTR stock.

XMTR Stock Performance Analysis: Revenue Growth but Decline in Net Income and EPS – February 29, 2024

On February 29, 2024, XMTR stock had a mixed performance based on the financial data provided by CNN Money. The company reported a total revenue of $381.05 million for the past year, showing a significant increase of 74.53% compared to the previous year. Additionally, the total revenue for the third quarter of the fiscal year was $118.93 million, indicating a 7.13% increase from the previous quarter.

XMTR reported a net income of -$76.03 million for the past year, which represents a 23.86% decrease compared to the previous year. The net income for the third quarter was -$12.02 million, showing a 54.72% increase from the previous quarter.

In terms of earnings per share (EPS), XMTR reported a negative EPS of -$1.61 for the past year, marking a 22.59% decrease from the previous year. The EPS for the third quarter was -$0.25, indicating a 54.85% increase from the previous quarter.

Overall, the financial performance of XMTR on February 29, 2024, reflected a mixed bag of results. While the company experienced significant revenue growth, there were declines in net income and EPS compared to the previous year. However, the positive growth in net income and EPS from the previous quarter suggests that XMTR may be on a path to recovery. Investors will need to closely monitor the company’s financial performance in the coming quarters to assess its long-term prospects.

Tags: XMTR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ blue chart

Barclays Analyst Adjusts Price Target for Oceaneering International

Healthcare cloud based

GH Research Reports Significant Net Loss in Second Quarter of 2023

Finances and charts

Demystifying the EB-5 Journey: Understanding Costs and Fees

Recommended

OHI stock news

Bel Fuse Director Sells 56700 Worth of Shares Amid Financial Challenges

2 years ago
I-Mab Stock

NovaBridge Biosciences Unveils Promising Clinical Trial Data and Strategic Rebranding

5 months ago
Nvidia Stock

Nvidia’s Key Supplier Signals Unwavering AI Demand

2 months ago
Silber Stock

Silver’s Perfect Storm: A Market Poised for Breakout

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Hain Celestial Sheds Snack Division in Strategic Overhaul

Trending

SOXX ETF Stock
Commodities

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

by Kennethcix
March 25, 2026
0

The semiconductor industry finds itself navigating a complex landscape where geopolitical developments intersect with tangible supply chain...

Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026
Humacyte Stock

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance
  • Figma Embraces Third-Party AI to Power Its Design Ecosystem

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com